EUVIMEDEUVIMED entdecken
Crossref

Impact of the 2023 FIGO staging revision on MRI diagnostic accuracy in FIGO 2009 stage I endometrial cancer

Su Lim Lee iD, Yu Ri Shin, Hokun Kim, Sung Eun Rha

Abdominal Radiology · 2025

DOI: 10.1007/s00261-025-05174-6 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Su Lim Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: This study aimed to evaluate the diagnostic performance of Magnetic Resonance Imaging (MRI) for staging patients with International Federation of Gynecology and Obstetrics (FIGO) stage I endometrial cancer, by comparing the original 2009 system with the revised 2023 system. MATERIALS AND METHODS: This retrospective study included 432 patients (mean age, 54.9 years) with histopathologically confirmed FIGO 2009 stage I endometrial cancer who underwent preoperative MRI. The patients were categorized into non-aggressive (n = 364; low-grade endometrioid histology) and aggressive (n = 68; grade 3 endometrioid or non-endometrioid histology, including serous, clear cell carcinoma, and carcinosarcoma) tumor groups. Preoperative MRI-based assessment of myometrial invasion was compared with histopathological results to assess the myometrial invasion depth, which was classified as no invasion, superficial invasion (< 50%), and deep invasion (≥ 50%). Diagnostic accuracy, sensitivity, specificity, and agreement of preoperative MRI-based staging determination were calculated for both FIGO 2009 and 2023 systems. RESULTS: In non-aggressive tumors, the 2009 FIGO staging demonstrated superior accuracy (kappa 0.82, 95% CI 0.74-0.89) compared to the 2023 staging (kappa 0.66, 95% CI 0.59-0.74), with a statistically significant difference (p = 0.0029). MRI performance varied across invasion depths, with excellent diagnostic accuracy for deep myometrial invasion (sensitivity, 87.0%; specificity, 95.9%). For aggressive tumors, no significant difference was observed between the two staging systems (p = 0.160). Subgroup analysis demonstrated that the presence of lymphovascular space invasion did not result in statistically significant differences in diagnostic agreement between MRI and pathological staging (p = 0.452). CONCLUSION: This study provides evidence that 2023 FIGO staging revisions present measurable challenges for MRI-based staging accuracy, particularly in the assessment of non-aggressive endometrial tumors confined to the uterus. Despite these challenges, MRI maintains reliable diagnostic performance for detecting deep myometrial invasion in uterus-confined disease, supporting its continued utility in preoperative staging protocols. KEY TAKE‑HOME: Radiologists should recognize the statistically significant reduction in diagnostic accuracy for detecting the absence of myometrial invasion under FIGO 2023 criteria, particularly in non-aggressive endometrioid tumors, and consider integrating complementary quantitative imaging parameters or molecular biomarkers to enhance the preoperative staging precision.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsMagnetic Resonance ImagingHumansFemaleNeoplasm StagingMiddle AgedRetrospective StudiesSensitivity and SpecificityAgedNeoplasm InvasivenessAdultAged, 80 and overReproducibility of Results

Stichwörter der Autor:innen

Diagnostic imagingEndometrial neoplasmsMagnetic resonance imagingNeoplasm stagingSensitivity and specificity

Autor:innen und Institutionen

  • Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. crystal57@daum.net.

ORCID-Profile: Su Lim Lee

Zitieren

APA

Lee, S. L., Shin, Y. R., Kim, H., & Rha, S. E. (2025). Impact of the 2023 FIGO staging revision on MRI diagnostic accuracy in FIGO 2009 stage I endometrial cancer. Abdominal Radiology. https://doi.org/10.1007/s00261-025-05174-6

Vancouver

Lee SL, Shin YR, Kim H, Rha SE. Impact of the 2023 FIGO staging revision on MRI diagnostic accuracy in FIGO 2009 stage I endometrial cancer. Abdominal Radiology. 2025. doi:10.1007/s00261-025-05174-6

BibTeX
@article{Lee2025,
  author = {Lee, Su Lim and Shin, Yu Ri and Kim, Hokun and Rha, Sung Eun},
  title = {Impact of the 2023 FIGO staging revision on MRI diagnostic accuracy in FIGO 2009 stage I endometrial cancer},
  journal = {Abdominal Radiology},
  year = {2025},
  doi = {10.1007/s00261-025-05174-6}
}
Kostenlos starten →